Allergic conjunctivitis: improved QOL with olopatadine plus loratadine

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.326, 2001-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis

By Nickels Andrew S   Dimov Vesselin   Wolf Raoul  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1593-1599

Informa Healthcare

Access to resources Recommend Favorite

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell

By Leonardi Andrea   Quintieri Luigi  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 969-981

Informa Healthcare

Access to resources Recommend Favorite

Olopatadine improves symptoms, QOL in seasonal allergic rhinitis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 451, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Olopatadine improves symptoms, QOL in seasonal allergic rhinitis

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Olopatadine nasal spray significantly improves nose-related symptoms and QOL factors in patients with seasonal allergic rhinitis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 496, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite